20 January 2017 - The US FDA’s independent evaluation of medical products for safety and effectiveness prior to granting approval ...
19 January 2017 - Once daily treatment reduces persistent facial erythema associated with rosacea through 12 hours. ...
19 January 2017 - The U.S. FDA today approved Trulance (plecanatide) for the treatment of chronic idiopathic constipation in adult ...
19 January 2017 - Today the U.S. FDA is establishing the Oncology Center of Excellence (OCE) and appointing Dr. Richard ...
18 January 2017 - Days before Donald Trump’s inauguration as President of the United States, there's already a reality-TV-sized dose ...
19 January 2017 - Imbruvica will be a chemotherapy-free option for patients with marginal zone lymphoma who failed prior therapies. ...
18 January 2017 - To incentivise pharmaceutical manufacturers to invest in areas of unmet medical need, policy makers frequently propose extending ...
18 January 2017 - BI 695501 EMA and FDA applications are first biosimilar regulatory filings for Boehringer Ingelheim. ...
18 January 2017 - First reported fast track designation for LGMD2B treatment. ...
17 January 2017 - The US FDA has finally released for public consultation its long-awaited draft guidance detailing the agency's ...
18 January 2017 - Vantrela ER label describes the product’s abuse-deterrent properties against abuse in the three most common routes—oral, ...
17 January 2017 - The U.S. FDA has approved the first generic version of Xyrem (sodium oxybate) Oral Solution, to treat ...
18 January 2017 - One of the most common concerns raised when I meet with medical leaders is the need ...
18 January 2017 - We recognise that there is a high level of interest regarding FDA’s views on communications about ...
17 January 2017 - Patients with type 2 diabetes are treated with many drugs other than insulin. In 2014, Medicare paid ...